Yun Yang

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Wanhong Zhao, Jie Liu, Baiyan Wang et al. · Journal of Hematology & Oncology · 2018 · 526 citations · Full text

Immunology, Immunodominance, Immunotherapeutics +19

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Wanhong Zhao, Baiyan Wang, Lijuan Chen et al. · Journal of Hematology & Oncology · 2022 · 139 citations · Full text

Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

Wanhong Zhao, Jie Liu, Baiyan Wang et al. · Blood · 2018 · 42 citations

Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma

Yun Yang, Tian Xia, Ning Li et al. · Protein & Cell · 2012 · 39 citations · Full text

<scp>IL</scp>‐17A promotes the invasion–metastasis cascade via the <scp>AKT</scp> pathway in hepatocellular carcinoma

Qingguo Xu, Jian Yu, Xinggang Guo et al. · Molecular Oncology · 2018 · 31 citations · Full text